NCT05284110

Brief Summary

This study will verify the effects of breaking up sitting time with short bouts of light intensity walking on vascular function in women with rheumatoid arthritis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
12

participants targeted

Target at below P25 for not_applicable rheumatoid-arthritis

Timeline
Completed

Started Dec 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 24, 2022

Completed
21 days until next milestone

First Posted

Study publicly available on registry

March 17, 2022

Completed
9 months until next milestone

Study Start

First participant enrolled

December 1, 2022

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2024

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

October 4, 2023

Status Verified

October 1, 2023

Enrollment Period

1.4 years

First QC Date

February 24, 2022

Last Update Submit

October 3, 2023

Conditions

Keywords

physical activityrheumatic diseasesvascular function

Outcome Measures

Primary Outcomes (3)

  • Middle cerebral artery mean velocity (MCAV)

    MCAV will be assessed using continuous bilateral transcranial Doppler ultrasound.

    Change from baseline (hour 0) to hour 4 (post-intervention/control)

  • Middle cerebral artery mean velocity reactivity to carbon dioxide

    Participants will breathe a 5% carbon dioxide mixture for 3 min during which time MCAV reactivity to CO2 will be assessed using continuous bilateral transcranial Doppler ultrasound.

    Change from baseline (hour 0) to hour 4 (post-intervention/control)

  • Cerebral autoregulation

    Participants will be asked to complete a series of repeated sit to stand moves (coached by a member of the research team) for a 5-minute period, during which time MCAV will be assessed using continuous bilateral transcranial Doppler ultrasound. Beat by beat blood pressure will also be assessed using finger photoplethysmography.

    Change from baseline (hour 0) to hour 4 (post-intervention/control)

Secondary Outcomes (9)

  • Brachial artery endothelial function

    Change from baseline (hour 0) to hour 4 (post-intervention/control)

  • Finger blood pressure

    Change from baseline (hour 0) to hour 4 (post-intervention/control)

  • Superficial femoral artery endothelial function

    Change from baseline (hour 0) to hour 4 (post-intervention/control)

  • Skin blood flow response to hyperemia

    Change from baseline (hour 0) to hour 4 (post-intervention/control)

  • Stroop color-word test

    Change from baseline (hour 0) to hour 4 (post-intervention/control)

  • +4 more secondary outcomes

Study Arms (2)

Walking breaks (WALK)

EXPERIMENTAL

During this session, participants will be requested to remain seated during 4 hours, but the sitting will be interrupted every 30 min with a 3-min light-intensity walking.

Behavioral: Physical activity

Prolonged sitting (SIT)

NO INTERVENTION

During this session, participants be requested to remain seated during 4 uninterrupted hours (excepted for visiting the toilet) in a comfortable chair

Interventions

Multiple bouts of 3-min brisk walking, every 30 min, for 4 hours.

Also known as: Walking
Walking breaks (WALK)

Eligibility Criteria

Age18 Years - 60 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Adult women diagnosed with RA
  • From the Rheumatology Clinic at the Liverpool University Hospitals NHS Foundation Trust
  • Aged 18-60 yr
  • Non-smoker for at least 6months
  • Able to provide written informed consent.

You may not qualify if:

  • Cannot readily read and understand English.
  • Currently smoking or within last 6 months.
  • Alcohol consumption \>14units per week.
  • Symptoms of or established cardiovascular disease (except hypertension)
  • Previous stroke or myocardial infarction.
  • History of diabetes or respiratory disease or chronic kidney disease.
  • Musculoskeletal impairment/disability precluding physical activity
  • Unstable medication (change in medication within the 3 months)
  • Aged \<18 or \> 60 yr
  • Currently pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Research Institute for Sport and Exercise Sciences (RISES)

Liverpool, Merseyside, L3 3AF, United Kingdom

RECRUITING

MeSH Terms

Conditions

Arthritis, RheumatoidSedentary BehaviorMotor ActivityRheumatic Diseases

Interventions

ExerciseWalking

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System DiseasesBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaLocomotion

Central Study Contacts

Daniel Bannell, MPhil

CONTACT

David Low, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The researcher who will perform the vascular analysis will be blinded to the allocation order.
Purpose
OTHER
Intervention Model
CROSSOVER
Model Details: Participants with rheumatoid arthritis will attend the laboratory at Liverpool John Moores University on 2 occasions. During these visits, they will be submitted to the intervention or the control and will also undertake a series vascular tests prior- and post-intervention/control.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 24, 2022

First Posted

March 17, 2022

Study Start

December 1, 2022

Primary Completion

April 30, 2024

Study Completion

December 1, 2024

Last Updated

October 4, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

Locations